Kato Pharmaceuticals, Inc.
Records under this name other than the patents Kato Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Kato Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,977,385 | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye Term ended Term ended Apr 7, 2021 · From the USPTO record | Term ended | Term ended Apr 7, 2021 | From the USPTO record |
| US 7,008,960 | Agents for intravitreal administration to treat or prevent disorders of the eye Term ended Term ended Oct 7, 2020 · From the USPTO record | Term ended | Term ended Oct 7, 2020 | From the USPTO record |
| US 6,462,071 | Agents for intravitreal administration to treat or prevent disorders of the eye Term ended Term ended Mar 2, 2020 · From the USPTO record | Term ended | Term ended Mar 2, 2020 | From the USPTO record |
| US 8,691,874 | Treatment of ophthalmic disorders using urea Term ended Ended no later than Mar 2, 2020 · From the USPTO record | Term ended | Ended no later than Mar 2, 2020 | From the USPTO record |